Verséa Health and iRemedy Announce Strategic Joint Venture - Verséa
 

Verséa Health and iRemedy Announce Strategic Joint Venture

June 28, 2023by Verséa Health

Tampa, FL – June 28, 2023 – Verséa Health, Inc., a prominent provider of diagnostics and medical supplies for urgent care centers, and iRemedy Healthcare Companies, Inc. (“iRemedy”), a trailblazer in the medical supply e-commerce industry, are thrilled to announce their strategic joint venture. The collaboration aims to establish an integrated ecosystem of services tailored to meet the unique needs of urgent care facilities across the nation, driving their growth and success.

With a shared vision to tackle inefficiencies in the procurement process, this joint venture will offer a much-needed solution for urgent care providers. Leveraging iRemedy’s cutting-edge procurement technology and Verséa’s comprehensive understanding of the urgent care sector, the collaboration will introduce a specialized platform that simplifies, streamlines, and elevates the supply purchasing process. In addition, the platform will provide an expanded range of services, including customized content and Continuing Medical Education (CME) programs, designed to support urgent care operations and facilitate their expansion of locations and service offerings.

Tony Paquin, CEO of iRemedy, expressed his enthusiasm, stating, ” This partnership with Verséa is a significant step forward in our commitment to revolutionize the healthcare supply chain. By combining our respective strengths, we’re confident that our new platform will significantly improve the procurement process, allowing urgent care providers to focus more on their primary mission – patient care.”

Sean Fetcho, CEO of Verséa Health, added, ” Verséa Health was born from a desire to transform healthcare to improve quality and access to care, and we believe urgent care centers are on the frontlines of much of that change.  We’ve seen firsthand the challenges faced by urgent care centers, who are often overlooked or misunderstood by the traditional distributors, when looking for services or procuring medical supplies. Partnering with iRemedy and utilizing their robust ecommerce infrastructure allows us to deliver a seamless, efficient, and effective solution. This collaboration is a testament to Verséa’s commitment to supporting urgent care centers with innovative, practical solutions.”

About Verséa Health, Inc. Verséa Health, Inc.

(“Verséa”), headquartered in Tampa, FL, is a transformative healthcare company founded by experienced business executives and guided by an Advisory Board comprised of leading academic and multidisciplinary clinical medical advisors. Through strategic industry partnerships and proprietary research and development, the company delivers innovative, high-value diagnostic and therapeutic solutions to help improve healthcare quality and access. To learn more, visit: www.versea.com.

About The iRemedy Healthcare Companies

iRemedy is a trusted and reliable partner for acquiring medical supplies. They service over 10,000 healthcare provider clients nationwide. iRemedy guarantees access to verified supplies by sourcing directly from established manufacturers and distributors around the world. Their industry-leading technology and group purchasing power enable transparency and competition, driving consistently low pricing for customers every day. iRemedy is headquartered in Stuart, Florida and has offices in New York, California and Washington, and a distribution center in Florida. For more information, please visit www.iRemedy.com.

Further details regarding the new platform, including its official launch date, will be announced in the coming months. For more information about this joint venture, please contact James Olin at 207-604-4411 or jolin@versea.com